TENAX THERAPEUTICS, INC. (TENX) › Capital ExpendituresTENAX THERAPEUTICS, INC. (TENX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $240.8K2012: $17.7K2013: $17.2K2014: $9.8K2015: $4.2K2016: $2.9K2017: $4.5K2018: $7.6K2019: $3.6K2020: $3.5K2021: $5.3K2022: $2.3K$2.3K2011Capital Expenditures (USD)2022Fiscal YearCapital ExpendituresChange YoY2022$2.3K-55.8%2021$5.3K+50.5%2020$3.5K-2.4%2019$3.6K-52.9%2018$7.6K+67.4%2017$4.5K+57.3%2016$2.9K-31.9%2015$4.2K-56.8%2014$9.8K-43.0%2013$17.2K-2.6%2012$17.7K-92.7%2011$240.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share